Prothena Corporation Public Limited Company Asset Turnover Ratio (PRTA), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Prothena Corporation Public Limited Company  (NASDAQ: PRTA)
 

Prothena Public Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Prothena Corporation Public Limited Company asset turnover ratio, the ability of Prothena Corporation Public Limited Company's assets to generate revenue in the first quarter 2026, increased sequentially to 0.16 in the first quarter (Mar 31 2026), PRTA's balance sheet remain strong.

Within sector 140 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 2881, from total ranking in the fourth quarter 2025 at 3433.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRTA Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -28.01 % -39.2 % -40.97 % -38.35 % -20.65 %
Y / Y Revenue Change 1706.36 % -99.01 % 148.97 % -96.65 % 5556 %
Asset Turnover Ratio (TTM) 0.16 0.02 0.03 0.02 0.25
PRTA's Total Ranking # 2881 # 3433 # 3498 # 0 # 1034
Seq. Asset Change 7.07 % -5.39 % -11.69 % -19.52 % -9.57 %
Seq. Revenue Change 243157.14 % -99.13 % -45.36 % 56.29 % 33.21 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 141
Healthcare Sector # 436
Overall Market # 2881

Asset Turnover Ratio Statistics
High Average Low
0.45 0.09 0
(Sep 30 2021)   (Sep 30 2019)




PRTA Company Profile • Back to PRTA Efficiency Comparisons • Compare PRTA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Perrigo Company Plc  0.46 $ 4,177.500  Millions$ 9,174.150  Millions
Vireo Growth Inc.  0.45 $ 350.469  Millions$ 771.053  Millions
Collegium Pharmaceutical Inc   0.45 $ 739.250  Millions$ 1,627.187  Millions
Rapid Micro Biosystems Inc   0.45 $ 33.753  Millions$ 74.302  Millions
Integra Lifesciences Holdings Corp  0.45 $ 1,644.510  Millions$ 3,623.521  Millions
Quidelortho Corp  0.45 $ 2,657.200  Millions$ 5,863.050  Millions
Sangamo Therapeutics Inc   0.45 $ 34.557  Millions$ 76.478  Millions
Sutro Biopharma Inc   0.45 $ 99.608  Millions$ 221.958  Millions
Amphastar Pharmaceuticals Inc   0.44 $ 720.530  Millions$ 1,639.754  Millions
Outset Medical Inc   0.43 $ 116.783  Millions$ 270.002  Millions
Cytek Biosciences Inc   0.43 $ 202.548  Millions$ 474.724  Millions
United Therapeutics Corporation  0.42 $ 3,169.800  Millions$ 7,463.325  Millions
Lemaitre Vascular Inc   0.42 $ 256.515  Millions$ 605.219  Millions
Zevra Therapeutics Inc   0.42 $ 115.073  Millions$ 272.426  Millions
Brightspring Health Services Inc   0.42 $ 2,595.630  Millions$ 6,154.930  Millions
Surgery Partners Inc   0.42 $ 3,343.600  Millions$ 8,015.800  Millions
Biomarin Pharmaceutical Inc  0.41 $ 3,242.316  Millions$ 7,814.062  Millions
Alpha Teknova Inc   0.41 $ 43.582  Millions$ 105.088  Millions
Siga Technologies Inc  0.41 $ 93.777  Millions$ 226.447  Millions
Sensus Healthcare Inc   0.41 $ 22.907  Millions$ 55.433  Millions
Rxsight Inc   0.41 $ 127.178  Millions$ 308.337  Millions
Kestra Medical Technologies Ltd   0.41 $ 93.819  Millions$ 229.353  Millions
Tenon Medical Inc   0.41 $ 4.597  Millions$ 11.270  Millions
Vanda Pharmaceuticals Inc   0.41 $ 217.782  Millions$ 537.090  Millions
Dyadic International Inc   0.41 $ 3.808  Millions$ 9.392  Millions
Syndax Pharmaceuticals Inc   0.40 $ 217.174  Millions$ 537.579  Millions
Bausch Health Companies Inc   0.40 $ 10,531.000  Millions$ 26,238.500  Millions
Becton Dickinson And Company  0.40 $ 21,366.000  Millions$ 53,975.000  Millions
Zai Lab Limited  0.39 $ 453.280  Millions$ 1,147.791  Millions
Bionano Genomics Inc   0.39 $ 28.738  Millions$ 73.365  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.